Becton, Dickinson ordered to pay $4.8M in hernia mesh trial – Bloomberg

Aug. 29, 2022 2:03 PM ETBecton, Dickinson and Company (BDX)By: Dulan Lokuwithana, SA News Editor1 Comment

BD Canada"s head office building in Mississauga, On, Canada.

JHVEPhoto/iStock Editorial via Getty Images

  • A jury on Friday concluded that health equipment maker Becton, Dickinson (NYSE:BDX) must award $4.8M as damages to a man who claimed that a hernia mesh sold by one of its units damaged his bowels, impairing his ability to work, Bloomberg reported Monday.
  • The verdict issued in state court in Providence, Rhode Island, on Monday relates to BDX’s Ventralex hernia-mesh kit sold by the company’s Davol unit.
  • The decision follows a case brought by a municipal worker in Hawaii who claimed that the company defectively designed the product and did not properly warn about its health risks., Bloomberg reported quoting his attorney Jonathan Orent.
  • In April, an Ohio jury ordered BDX to pay $255K as damages to man in a similar trial over hernia mesh products sold by C.R. Bard before Becton (BDX) acquired the company in 2017.

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.